News
BBP
51.69
-1.12%
-0.59
Weekly Report: what happened at BBP last week (0408-0412)?
Weekly Report · 2d ago
Hor Kew Reports Increased Profits After Audit
TipRanks · 2d ago
Weekly Report: what happened at BBP last week (0401-0405)?
Weekly Report · 04/08 11:37
Weekly Report: what happened at BBP last week (0325-0329)?
Weekly Report · 04/01 11:33
Weekly Report: what happened at BBP last week (0318-0322)?
Weekly Report · 03/25 11:37
Weekly Report: what happened at BBP last week (0311-0315)?
Weekly Report · 03/18 11:35
Weekly Report: what happened at BBP last week (0304-0308)?
Weekly Report · 03/11 11:31
Why Biotech Stocks May Be Ready For A Recovery
Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.
Seeking Alpha · 03/09 08:59
Weekly Report: what happened at BBP last week (0226-0301)?
Weekly Report · 03/04 11:35
Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?
Seeking Alpha · 02/27 18:15
Weekly Report: what happened at BBP last week (0219-0223)?
Weekly Report · 02/26 11:49
Weekly Report: what happened at BBP last week (0212-0216)?
Weekly Report · 02/19 11:52
Weekly Report: what happened at BBP last week (0205-0209)?
Weekly Report · 02/12 11:39
Weekly Report: what happened at BBP last week (0129-0202)?
Weekly Report · 02/05 11:50
Weekly Report: what happened at BBP last week (0122-0126)?
Weekly Report · 01/29 11:36
Weekly Report: what happened at BBP last week (0115-0119)?
Weekly Report · 01/22 11:41
Weekly Report: what happened at BBP last week (0108-0112)?
Weekly Report · 01/15 11:37
Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week
Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2 billion. San Diego’s Ambrx Biopharmas will be acquired by Johnson & Johnson for $2billion. GSK plans to acquire Aiolos Bio for $1 billion upfront and up to $400 million.
Seeking Alpha · 01/14 08:40
Biotech ETFs Stage Solid Comeback at the Start of 2024
NASDAQ · 01/09 16:05
Healthcare Outlook 2024
Healthcare sector was flat in 2023 year as a result of unique issues. Drug price regulation will be a serious challenge for the sector this year. We expect the broader S&P Healthcare Index to rise 10% in 2024. The healthcare sector is expected to gain 5%-10% in the first half of 2024.
Seeking Alpha · 01/08 13:31
More
Webull provides a variety of real-time BBP stock news. You can receive the latest news about Virtus LifeSci Biotech Products ETF through multiple platforms. This information may help you make smarter investment decisions.